BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15785045)

  • 21. [Lectin binding of psoriatic skin].
    Wollina U; Hipler C; Henkel U; Schaarschmidt H; Knopf B
    Z Hautkr; 1986 Sep; 61(17):1241-9. PubMed ID: 3776279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased endothelemia as an indirect marker of changes in the blood vessel endothelium in psoriasis.
    Sochorova R; Svecova D; Sinka L; Rybarova L
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):556-9. PubMed ID: 15324392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis.
    Creamer D; Allen MH; Sousa A; Poston R; Barker JN
    Br J Dermatol; 1997 Jun; 136(6):859-65. PubMed ID: 9217817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum samples from patients with active psoriasis enhance lymphocyte-induced angiogenesis and modulate endothelial cell proliferation.
    Majewski S; Tigalonowa M; Jabłónska S; Polakowski I; Janczura E
    Arch Dermatol; 1987 Feb; 123(2):221-5. PubMed ID: 2434032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormality of water barrier function in psoriasis. Role of ceramide fractions.
    Motta S; Monti M; Sesana S; Mellesi L; Ghidoni R; Caputo R
    Arch Dermatol; 1994 Apr; 130(4):452-6. PubMed ID: 8166482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perfusion Intensity Correlates with Expression Levels of Psoriasis-Related Genes and Proteins.
    Hendriks AG; Steenbergen W; Zeeuwen PL; Schalkwijk J; Hondebrink E; Klitsie MA; Schreurs R; van de Kerkhof PC; Seyger MM
    Skin Pharmacol Physiol; 2015; 28(6):296-306. PubMed ID: 26361329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of skin blood flow and color on lesional and control sites during PUVA therapy for psoriasis.
    Suh DH; Kwon TE; Kim SD; Park SB; Kwon OS; Eun HC; Youn JI
    J Am Acad Dermatol; 2001 Jun; 44(6):987-94. PubMed ID: 11369911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Formation of dermo-epidermal hyperplasia in psoriasis].
    Pierard GE; Pierard-Franchimont C
    Ann Dermatol Venereol; 1983; 110(11):891-7. PubMed ID: 6666933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pseudo-elongation of capillaries in psoriatic plaques.
    Bacharach-Buhles M; el Gammal S; Panz B; Altmeyer P
    Acta Derm Venereol Suppl (Stockh); 1994; 186():133-7. PubMed ID: 8073813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced density of T6-positive epidermal Langerhans' cells in uninvolved skin of patients with psoriasis.
    Oxholm A; Oxholm P; Staberg B
    Acta Derm Venereol; 1987; 67(1):8-11. PubMed ID: 2436422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psoriasis vulgaris--unchanged endothelial reactivity with histochemical markers].
    Wollina U; Hipler C; Knopf B; Koch HJ
    Z Hautkr; 1989 Oct; 64(10):925-7. PubMed ID: 2686249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical coherence tomography imaging of psoriasis vulgaris: correlation with histology and disease severity.
    Morsy H; Kamp S; Thrane L; Behrendt N; Saunder B; Zayan H; Elmagid EA; Jemec GB
    Arch Dermatol Res; 2010 Mar; 302(2):105-11. PubMed ID: 19894055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis in normal and psoriatic skin.
    Wolf JE
    Lab Invest; 1989 Aug; 61(2):139-42. PubMed ID: 2474088
    [No Abstract]   [Full Text] [Related]  

  • 35. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
    Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.
    Chang EY; Hammerberg C; Fisher G; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
    Arch Dermatol; 1992 Nov; 128(11):1479-85. PubMed ID: 1359841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
    Bhawan J; Bansal C; Whren K; Schwertschlag U;
    J Cutan Pathol; 2004 Aug; 31(7):471-6. PubMed ID: 15239676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mesenchymal stem cell profile in psoriasis.
    Orciani M; Campanati A; Salvolini E; Lucarini G; Di Benedetto G; Offidani A; Di Primio R
    Br J Dermatol; 2011 Sep; 165(3):585-92. PubMed ID: 21623755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous vascular patterns in psoriasis.
    Micali G; Lacarrubba F; Musumeci ML; Massimino D; Nasca MR
    Int J Dermatol; 2010 Mar; 49(3):249-56. PubMed ID: 20465659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.